Showing results (231-240 of 699) with videos related to

Sort By:
Pageof 70
Blood Cancer Journal|August 7, 2025
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresisElham Askari, Angela Dispenzieri, Francis K Buadi, et al.
American Journal of Hematology|February 10, 2017
Hematology patient reported symptom screen to assess quality of life for AL amyloidosisRahma Warsame, Shaji K Kumar, Morie A Gertz, et al.
Blood Advances|November 13, 2024
Retreatment of multiple myeloma with previously refractory drugsUtkarsh Goel, Charalampos Charalampous, Prashant Kapoor, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 24, 2019
Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosisEli Muchtar, Angela Dispenzieri, Dragan Jevremovic, et al.
Leukemia|October 17, 2018
Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
American Journal of Hematology|June 11, 2021
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trialsM Hasib Sidiqi, Abdullah S Al Saleh, Shaji K Kumar, et al.
Annals of Medicine|March 9, 2017
Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognitionEli Muchtar, Angela Dispenzieri, Martha Q Lacy, et al.
Mayo Clinic Proceedings|October 8, 2016
Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and OutcomeEli Muchtar, Daniele Derudas, Michelle Mauermann, et al.
British Journal of Haematology|July 13, 2017
Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantationEli Muchtar, Angela Dispenzieri, Martha Q Lacy, et al.
American Journal of Hematology|November 25, 2021
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patientsPatrick W Mellors, Taxiarchis Kourelis, Ronald S Go, et al.
Pageof 70